Tubacin增敏在胱氨酸剥夺条件下三阴型乳腺癌铁死亡
Tubacin plus Erastin Treatment Sensitizes Cell Ferroptosis of Triple Negative Breast Neoplasms
DOI: 10.12677/ACM.2023.1351222, PDF,    科研立项经费支持
作者: 吴灿章*, 敬 波, 郑武平, 吴煌福#:海南医学院第二附属医院甲乳外科,海南 海口
关键词: 三阴型乳腺癌细胞死亡TubacinErastinFerroptosisTriple Negative Breast Neoplasms Cell Death Tubacin Erastin Ferroptosis
摘要: 目的:Tubacin可以转变恶性肿瘤的胱氨酸不敏感的状态,我们研究主要目的是验证Tubacin在胱氨酸剥夺条件下处理三阴型乳腺癌细胞HCC38的实际效果,并验证细胞死亡类型是否为铁死亡。方法:将细胞株HCC38在DMSO、Tubacin、Erastin、及Tubacin联合Erastin四组条件下培养,通过7-AAD、LDH、ROS及脂质过氧化物检测细胞死亡及类型。结果:1) 在胱氨酸剥夺处理条件下加入Tubacin,HCC38细胞死亡增加;2) Tubacin联合Erastin处理HCC38,细胞死亡显著增加;3) Tubacin联合Erastin处理的HCC38,细胞脂质过氧化物显著和盘状结构域受体2增多。结论:Tubacin增敏在胱氨酸剥夺条件下三阴型乳腺癌铁死亡。
Abstract: Purpose: Tubain can change the cystine insensitive state of malignant tumors. Our main purpose is to verify the actual effect of Tubain on HCC38 cells of triple negative breast cancer under the condi-tion of cystine deprivation, and to verify whether the type of cell death is iron death. Methods: Cell line HCC38 was cultured under four conditions: DMSO, tubacin, erastin, and tubacin plus erastin, and cell death and types were determined by 7-AAD, LDH, ROS, and lipid peroxides. Results: 1) Ad-dition of tubacin under cystine deprivation treatment conditions increased HCC38 cell death; 2) Treatment of HCC38 with tubacin in combination with erastin significantly increased cell death; 3) HCC38, treated with tubacin in combination with erastin, showed a significant increase in cellular lipid peroxides and discoidin domain receptor 2. Conclusions: Tubacin sensitizes iron death in triple negative breast cancer under cystine deprived conditions.
文章引用:吴灿章, 敬波, 郑武平, 吴煌福. Tubacin增敏在胱氨酸剥夺条件下三阴型乳腺癌铁死亡[J]. 临床医学进展, 2023, 13(5): 8741-8748. https://doi.org/10.12677/ACM.2023.1351222

参考文献

[1] Poggio, F., Bruzzone, M., Ceppi, M., et al. (2018) Platinum-Based Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis. Annals of Oncology, 29, 1497-1508. [Google Scholar] [CrossRef] [PubMed]
[2] Akins, N.S., Nielson, T.C. and Le, H.V. (2018) Inhibition of Glycol-ysis and Glutaminolysis: An Emerging Drug Discovery Approach to Combat Cancer. Current Topics in Medicinal Chemistry, 18, 494-504. [Google Scholar] [CrossRef] [PubMed]
[3] Vander Heiden, M.G., Cantley, L.C. and Thompson, C.B. (2009) Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation. Science, 324, 1029-1033. [Google Scholar] [CrossRef] [PubMed]
[4] Yuneva, M., Zamboni, N., Oefner, P., et al. (2007) Defi-ciency in Glutamine but Not Glucose Induces MYC-Dependent Apoptosis in Human Cells. Journal of Cell Biology, 178, 93-105. [Google Scholar] [CrossRef] [PubMed]
[5] Dixon, S.J., Lemberg, K.M., Lamprecht, M.R., et al. (2012) Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death. Cell, 149, 1060-1072. [Google Scholar] [CrossRef] [PubMed]
[6] 徐畅, 黄楠, 孙奋勇. 铁死亡在肿瘤中的研究进展[J]. 同济大学学报, 2021, 42(3): 432-440.
[7] Schonberg, D.L., Miller, T.E., Wu, Q., et al. (2015) Preferential Iron Trafficking Characterizes Glioblastoma Stem- Like Cells. Cancer Cell, 28, 441-455. [Google Scholar] [CrossRef] [PubMed]
[8] 王慧星, 韩晨阳, 李全波, 刘靖芷, 马文庭, 周国明, 蒋宁, 史可梅. 铁死亡在脂多糖诱导巨噬细胞损伤小鼠模型中的增强作用[J]. 中华疼痛学杂志, 2021, 17(3): 242-249.
[9] Miller, L.D., Coffman, L.G., Chou, J.W., et al. (2011) An Iron Regulatory Gene Signature Predicts Out-come in Breast Cancer. Cancer Research, 71, 6728-6737. [Google Scholar] [CrossRef
[10] Sornjai, W., Nguyen Van Long, F., Pion, N., et al. (2020) Iron and Hepcidin Mediate Human Colorectal Cancer Cell Growth. Chemico-Biological Interactions, 319, Article ID: 109021. [Google Scholar] [CrossRef] [PubMed]
[11] Tesfay, L., Clausen, K.A., Kim, J.W., et al. (2015) Hep-cidin Regulation in Prostate and Its Disruption in Prostate Cancer. Cancer Research, 75, 2254-2263. [Google Scholar] [CrossRef
[12] Ungard, R.G., Linher-Melville, K., Nashed, M.G., et al. (2019) xCT Knockdown in Human Breast Cancer Cells Delays Onset of Cancer-Induced Bone Pain. Molecular Pain, 15. [Google Scholar] [CrossRef] [PubMed]
[13] Chen, M.S., Wang, S.F., Hsu, C.Y., et al. (2017) CHAC1 Deg-radation of Glutathione Enhances Cystine-Starvation- Induced Necroptosis and Ferroptosis in Human Triple Negative Breast Cancer Cells via the GCN2-eIF2α-ATF4 Pathway. Oncotarget, 8, 114588-114602. [Google Scholar] [CrossRef] [PubMed]
[14] Yang, W.S., SriRamaratnam, R., Welsch, M.E., et al. (2014) Regu-lation of Ferroptotic Cancer Cell Death by GPX4. Cell, 156, 317-331. [Google Scholar] [CrossRef] [PubMed]
[15] Yu, M., Gai, C., Li, Z., et al. (2019) Targeted Exo-some-Encapsulated Erastin Induced Ferroptosis in Triple Negative Breast Cancer Cells. Cancer Science, 110, 3173-3182. [Google Scholar] [CrossRef] [PubMed]
[16] Wu, X., Liu, C., Li, Z., et al. (2020) Regulation of GSK3β/Nrf2 Signaling Pathway Modulated Erastin-Induced Ferroptosis in Breast Cancer. Molecular and Cellular Biology, 473, 217-228. [Google Scholar] [CrossRef] [PubMed]
[17] Chen, C., Xie, B., Li, Z., et al. (2022) Fascin Enhances the Vul-nerability of Breast Cancer to Erastin-Induced Ferroptosis. Cell Death & Disease, 13, Article No. 150. [Google Scholar] [CrossRef] [PubMed]
[18] Tang, X., Ding, C.K., Wu, J., et al. (2017) Cystine Addiction of Triple-Negative Breast Cancer Associated with EMT Augmented Death Signaling. Oncogene, 36, 4235-4242. [Google Scholar] [CrossRef] [PubMed]
[19] Marcus, A.I., Zhou, J., O’Brate, A., et al. (2005) The Synergistic Com-bination of the Farnesyl Transferase Inhibitor Lonafarnib and Paclitaxel Enhances Tubulin Acetylation and Requires a Functional Tubulin Deacetylase. Cancer Research, 65, 3883-3893. [Google Scholar] [CrossRef
[20] Yu, S., Cai, X., Wu, C., et al. (2017) Targeting HSP90-HDAC6 Regulating Network Implicates Precision Treatment of Breast Cancer. International Journal of Biologi-cal Sciences, 13, 505-517. [Google Scholar] [CrossRef] [PubMed]
[21] Miyamoto, K., Watanabe, M., Boku, S., et al. (2020) xCT Inhibition Increases Sensitivity to Vorinostat in a ROS- Dependent Manner. Cancers (Basel), 12, Article No. 827. [Google Scholar] [CrossRef] [PubMed]
[22] Erić, I., Petek Erić, A., Kristek, J., et al. (2018) Breast Cancer in Young Women: Pathologic and Immunohistochemical Features. Acta Clinica Croatica, 57, 497-502. [Google Scholar] [CrossRef] [PubMed]
[23] So, J.Y., Ohm, J., Lipkowitz, S. and Yang, L. (2022) Triple Nega-tive Breast Cancer (TNBC): Non-Genetic Tumor Heterogeneity and Immune Microenvironment: Emerging Treatment Options. Pharmacology & Therapeutics, 237, Article ID: 108253. [Google Scholar] [CrossRef] [PubMed]
[24] Saito, Y. and Soga, T. (2021) Amino Acid Transporters as Emerging Therapeutic Targets in Cancer. Cancer Science, 112, 2958-2965. [Google Scholar] [CrossRef] [PubMed]
[25] Lee, N., Carlisle, A.E., Peppers, A., et al. (2021) xCT-Driven Expression of GPX4 Determines Sensitivity of Breast Cancer Cells to Ferroptosis Inducers. Antioxidants (Basel), 10, Article No. 317. [Google Scholar] [CrossRef] [PubMed]
[26] Lin, C.C., Mabe, N.W., Lin, Y.T., et al. (2020) RIPK3 Upregulation Confers Robust Proliferation and Collateral Cystine-Dependence on Breast Cancer Recurrence. Cell Death & Differentia-tion, 27, 2234-2247. [Google Scholar] [CrossRef] [PubMed]
[27] Mabe, N.W., Garcia, N.M.G., Wolery, S.E., et al. (2020) G9a Promotes Breast Cancer Recurrence through Repression of a Pro-Inflammatory Program. Cell Reports, 33, Article ID: 108341. [Google Scholar] [CrossRef] [PubMed]
[28] Tu, Z. and Karnoub, A.E. (2022) Mesenchymal Stem/Stromal Cells in Breast Cancer Development and Management. Seminars in Cancer Biology, 86, 81-92. [Google Scholar] [CrossRef] [PubMed]
[29] Grasset, E.M., Dunworth, M., Sharma, G., et al. (2022) Tri-ple-Negative Breast Cancer Metastasis Involves Complex Epithelial-Mesenchymal Transition Dynamics and Requires Vimentin. Science Translational Medicine, 14, eabn7571. [Google Scholar] [CrossRef] [PubMed]
[30] Zheng, D., Liu, J., Piao, H., Zhu, Z., Wei, R. and Liu, K. (2022) ROS-Triggered Endothelial Cell Death Mechanisms: Focus on Pyroptosis, Parthanatos, and Ferroptosis. Frontiers in Immunology, 13, Article ID: 1039241. [Google Scholar] [CrossRef] [PubMed]
[31] Niu, B., Liao, K., Zhou, Y., et al. (2021) Application of Gluta-thione Depletion in Cancer Therapy: Enhanced ROS- Based Therapy, Ferroptosis, and Chemotherapy. Biomaterials, 277, Article ID: 121110. [Google Scholar] [CrossRef] [PubMed]
[32] Feng, H., Schorpp, K., Jin, J., et al. (2020) Transferrin Receptor Is a Specific Ferroptosis Marker. Cell Reports, 30, 3411-3423.e7. [Google Scholar] [CrossRef] [PubMed]
[33] Park, E. and Chung, S.W. (2019) ROS-Mediated Autophagy In-creases Intracellular Iron Levels and Ferroptosis by Ferritin and Transferrin Receptor Regulation. Cell Death & Disease, 10, Article No. 822. [Google Scholar] [CrossRef] [PubMed]
[34] Chen, X., Kang, R., Kroemer, G. and Tang, D. (2021) Broadening Horizons: The Role of Ferroptosis in Cancer. Nature Reviews Clinical Oncology, 18, 280-296. [Google Scholar] [CrossRef] [PubMed]
[35] Chen, P.H., Wu, J., Ding, C.C., et al. (2020) Kinome Screen of Ferroptosis Reveals a Novel Role of ATM in Regulating Iron Metabolism. Cell Death & Differentiation, 27, 1008-1022. [Google Scholar] [CrossRef] [PubMed]
[36] Mitchell, A.V., Wu, J., Meng, F., et al. (2022) DDR2 Coordinates EMT and Metabolic Reprogramming as a Shared Effector of FOXQ1 and SNAI1. Cancer Research Communications, 2, 1388-1403. [Google Scholar] [CrossRef
[37] Lin, C.C., Yang, W.H., Lin, Y.T., et al. (2021) DDR2 Up-regulation Confers Ferroptosis Susceptibility of Recurrent Breast Tumors through the Hippo Pathway. Oncogene, 40, 2018-2034. [Google Scholar] [CrossRef] [PubMed]
[38] Aldana-Masangkay, G.I., Rodriguez-Gonzalez, A., Lin, T., et al. (2011) Tubacin Suppresses Proliferation and Induces Apoptosis of Acute Lymphoblastic Leukemia Cells. Leukemia & Lymphoma, 52, 1544-1555. [Google Scholar] [CrossRef] [PubMed]